Literature DB >> 12592576

Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations.

Angelika Pethran1, Rudolf Schierl, Karlheinz Hauff, Carl-Heinz Grimm, Karl-Siegfried Boos, Dennis Nowak.   

Abstract

OBJECTIVES: There is a risk of adverse health effects for personnel with occupational exposure to antineoplastic agents. The aim of the present longitudinal study was to identify, quantify, and evaluate potential health hazards of occupationally exposed workers in pharmaceutical and oncological departments with central processing units for drug preparation.
METHODS: One hundred operatives in 14 German hospital pharmacies and oncological departments underwent biological monitoring by providing urine samples up to four times over a period of 3 years.
RESULTS: All antineoplastic agents that were considered (cyclophosphamide, ifosfamide, doxorubicin, epirubicin and platinum from cisplatin and carboplatin), were found in urine samples in up to 40% of participants.
CONCLUSIONS: Despite standard safety precautions, such as the use of vertical laminar air flow safety cabinets, and personal protective clothing, incorporation of drugs was detected. Therefore, an environmental monitoring strategy should be developed in order to detect contamination and attempt to improve hygiene during work.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12592576     DOI: 10.1007/s00420-002-0383-8

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  19 in total

Review 1.  Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.

Authors:  Thomas H Connor; Christina C Lawson; Martha Polovich; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2014-09       Impact factor: 2.162

2.  Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.

Authors:  Jack R Pretty; Thomas H Connor; Ivan Spasojevic; Kristine S Kurtz; Jeffrey L McLaurin; Clayton B'Hymer; D Gayle Debord
Journal:  J Oncol Pharm Pract       Date:  2010-12-23       Impact factor: 1.809

3.  Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.

Authors:  Bettina Kopp; Rudolf Schierl; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

4.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

5.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

Review 6.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

7.  Antineoplastic drug contamination in the urine of Canadian healthcare workers.

Authors:  Chun-Yip Hon; Kay Teschke; Hui Shen; Paul A Demers; Scott Venners
Journal:  Int Arch Occup Environ Health       Date:  2015-01-28       Impact factor: 3.015

8.  Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors:  Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-06-20       Impact factor: 3.015

9.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

10.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.